newsfilter
← Latest News
Business Wire·

InVivo Therapeutics Announces Publication of 12- and 24-month Data for INSPIRE 1.0 Study in Peer-Reviewed Neurosurgery

Manuscript details patient outcomes through 24-month follow up visit InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) today announced the publication of a peer-reviewed manuscript in Neurosurgery describing the previously disclosed 12- and 24-month d